AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site F49A/M52A/L56A
Virus SARS-CoV-2
Mutation level Amino acid level
Gene/protein/region type ORF1ab(NSP7)
Gene ID 43740578
Country -
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample cell line
Variants -
Viral reference sequence NC 045512.2
Drug/antibody/vaccine -
Transmissibility -
Transmission mechanism -
Pathogenicity decrease
Pathogenicity mechanism Inspection of the crosslinking products of the NSP7-NSP8 mixtures revealed that most of the mutations on the heterodimeric interface I of NSP7 (NSP7F49A and NSP7L56A in Figure3C) and of NSP8 (NSP8F92A in Figure ​Figure3D) lead to an increased NSP8 dimeriz
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name ORF1ab polyprotein
Uniprot protein ID P0DTC1
Protein length 7096 amino acids
Protein description ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies.

Literature information:


Pubmed ID 33999154
Clinical information No
Disease -
Published year 2021
Journal NUCLEIC ACIDS RESEARCH
Title Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP
Author Mahamaya Biswal, Stephen Diggs, Duo Xu, Nelli Khudaverdyan, Jiuwei Lu
Evidence In contrast, NSP12 alone or any pairwise combination of NSP7, NSP8 and NSP12 fails to generate an appreciable level of RNA product (Figure5B), consistent with previous observations that the co-presence of NSP7 and NSP8 greatly boosts the RNA replication efficiency of NSP12-mediated RNA replication (6,10). Second, introduction of the mutations on the interface I of NSP7 (F49A: NSP7F49A, M52A: NSP7M52A, L56A: NSP7L56A and F49A/M52A/L56A: TM) or NSP8 (F92A: NSP8F92A) lead to a decrease of RdRP efficiency to various extents, with the NSP7 F49A/M52A/L56A triple mutation giving rise to a stronger effect than individual mutations ​(Figure5C), in line with the impairments of the RdRP assembly by these mutations.